M, P., L, L., DF, M., F, C., A, B., J, S., . . . R, G. (2026). Treosulfan/fludarabine versus thiotepa/busulfan/fludarabine for allogeneic haematopoietic cell transplantation in lymphoma in the post-transplant cyclophosphamide era: A GETH-TC study.
Citación estilo ChicagoM, Peña, et al. Treosulfan/fludarabine Versus Thiotepa/busulfan/fludarabine for Allogeneic Haematopoietic Cell Transplantation in Lymphoma in the Post-transplant Cyclophosphamide Era: A GETH-TC Study. 2026.
Cita MLAM, Peña, et al. Treosulfan/fludarabine Versus Thiotepa/busulfan/fludarabine for Allogeneic Haematopoietic Cell Transplantation in Lymphoma in the Post-transplant Cyclophosphamide Era: A GETH-TC Study. 2026.
Precaución: Estas citas no son 100% exactas.